Juan Vera

CIK: 0001755495

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MRKR

Marker Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

MRKR
Marker Therapeutics, Inc.
Oct 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
250K shares-
MRKR
Marker Therapeutics, Inc.
Feb 12, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-

		Type	Shares	Price		Ownership
Oct 31, 2025	MRKR Marker Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	250,000	-	-	Direct
Feb 12, 2025	MRKR Marker Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct

1-2 of 2 transactions

About Vera Juan

Vera Juan (SEC CIK 0001755495) files insider reports with the SEC as President and CEO of Marker Therapeutics, Inc. (MRKR).

Signal8 holds 2 ownership filings by Vera Juan, all Form 4s, filed between Feb 14, 2025 and Nov 4, 2025. Those filings report 2 transactions, from Feb 12, 2025 to Oct 31, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Vera Juan's filings is in HOUSTON, TX.

Recent filings by Vera Juan

Oct 31, 2025: Grant or award of MRKR derivative securities (Form 4, code A).
Feb 12, 2025: Grant or award of MRKR derivative securities (Form 4, code A).

Other insiders filing for Marker Therapeutics, Inc. (MRKR)

Knobil Katharine, Director
Eansor Norman David, Director
ELMS STEVE, Director
Corzo Kathryn Penkus, Director
New Enterprise Associates 16, L.P., 10% Owner

How to read Form 4 transaction codes